BioVie Inc. Enters ATM Sales Agreement to Offer $6.46M of Common Stock

What Happened
BioVie Inc. announced on September 11, 2026 that it entered into a sales agreement with A.G.P./Alliance Global Partners to offer and sell up to $6,464,341 of its Class A common stock. The shares may be sold from time to time as an at‑the‑market (ATM) offering under the company’s effective Form S‑3 registration statement (File No. 333-296924, declared effective June 29, 2026). A prospectus supplement was filed with the SEC on September 11, 2026.

Key Details

• Offering agent: A.G.P./Alliance Global Partners; offering format: at‑the‑market sales (including Nasdaq or other U.S. trading markets) or negotiated transactions with company approval.
• Maximum aggregate offering amount: $6,464,341 of Class A common stock.
• Agent compensation: 3.0% commission on gross proceeds; company will also reimburse certain agent expenses.
• Use of proceeds: general corporate purposes. The company is not obligated to sell any shares and may suspend or terminate the program; the registration will expire on the third anniversary of its initial effectiveness.

Why It Matters
This agreement gives BioVie a flexible way to raise up to $6.46 million by selling shares into the market as needed, which can help fund operations or other corporate needs without a single large equity issuance. Investors should note potential dilution if shares are sold and the cost of the program includes a 3% sales commission. The sales are subject to market conditions and the company’s discretion; no sales are guaranteed.